First Pacific Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10
Closed -$607 525
2026
Q1
$607 Buy
+10
New +$583 ﹤0.01% 592
2025
Q4
Sell
-7
Closed -$316 500
2025
Q3
$316 Buy
7
+4
+133% +$187 ﹤0.01% 493
2025
Q2
$139 Sell
3
-26
-90% -$1.28K ﹤0.01% 470
2025
Q1
$1.77K Buy
29
+21
+263% +$1.22K ﹤0.01% 467
2024
Q4
$453 Sell
8
-674
-99% -$37.7K ﹤0.01% 388
2024
Q3
$35.3K Hold
682
0.01% 213
2024
Q2
$28.3K Buy
682
+182
+36% +$8.14K 0.01% 201
2024
Q1
$27.1K Hold
500
0.01% 208
2023
Q4
$25.7K Hold
500
0.01% 207
2023
Q3
$29K Sell
500
-180
-26% -$11K 0.01% 180
2023
Q2
$43.5K Buy
+680
New +$45.6K 0.02% 158

Other funds holding BMY

First Pacific Financial's BMY Position: Q2 2026 in Review

First Pacific Financial sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 10 shares — an estimated $607 sold.

First Pacific Financial first reported a position in BMY in Q2 2023 and held it in 11 quarters. The position peaked at $43.5K in Q2 2023. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • First Pacific Financial reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • First Pacific Financial sold 10 Bristol-Myers Squibb shares in Q2 2026, an estimated $607.
  • First Pacific Financial first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 11 quarters.
  • First Pacific Financial's Bristol-Myers Squibb position peaked at $43.5K in Q2 2023.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on First Pacific Financial's 13F filing for Q2 2026, filed 20 Jul 2026.